Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.39 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25083688 | 0.82 | ALDH1A1 (0.46) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL7094098 | 0.82 | CYP2D6 (0.56) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL7426956 | 0.82 | CYP2D6 (0.50) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL2418182 | 0.81 | CYP2D6 (0.54) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL10136021 | 0.81 | ALDH1A1 (0.40) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL23729797 | 0.81 | HPGD (0.44) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL25029529 | 0.81 | EPHX2 (0.48) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL743998 | 0.80 | CYP2D6 (0.48) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL13669328 | 0.80 | CYP2D6 (0.48) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 | |
| SCHEMBL20111770 | 0.79 | ALDH1A1 (0.39) | CYP2D6CYP2C19EPHX2HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100136034-A1 | NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100136034-A1 | NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS | TNFRSF1A, TNFRSF9, CD40 | CYP2D6 1044/4885CYP2C19 1040/4885EPHX2 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.